The company is likely to report a 35.1 per cent fall in consolidated profit after tax (PAT) to Rs 126 crore year-on-year (YoY) for Q4FY2023, according to Zee Business Research. Chemical makers’ ...
At around 10:15 AM, shares of Aarti Drugs were trading 12.45 per cent higher at Rs 574.15 apiece on the BSE. The market capitalisation of the company stood at Rs 5,299.96 crore. The buyback amount ...